Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05673005 · ClinicalTrials.gov registry record · NA
MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT05673005 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 20 participants.
The verdict
NCT05673005, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The investigators are doing this research to evaluate the efficacy and safety of topical MED3000 therapy in men with persistent erectile dysfunction 1.5 to 4 years following radical prostatectomy surgery.
Interventions
- DEVICE MED3000 topical gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2024-08-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05673005
The ClinicalTrials.gov registry entry for NCT05673005 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MED3000 topical gel is the first listed.
NCT05673005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05673005 about?
NCT05673005 is a clinical study titled "MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction". The investigators are doing this research to evaluate the efficacy and safety of topical MED3000 therapy in men with persistent erectile dysfunction 1.5 to 4 years following radical prostatectomy surgery.
What is the current status of trial NCT05673005?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-04-01. Estimated completion is 2024-08-09.
What interventions are being tested in trial NCT05673005?
The interventions under investigation include: MED3000 topical gel (DEVICE).
Who is sponsoring clinical trial NCT05673005?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.